Liver transplantation for an HIV-positive patient in the era of highly active antiretroviral therapy

被引：29

作者：

Gow, PJ ^{[1
]}

Mutimer, D ^{[1
]}

机构：

[1] Queen Elizabeth Hosp, Liver & Hepatobiliary Unit, Birmingham B15 2TH, W Midlands, England

来源：

AIDS | 2001年 / 15卷 / 02期

关键词：

D O I：

10.1097/00002030-200101260-00029

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：291 / 292

页数：2

共 5 条

[1] AN OBSERVATIONAL STUDY OF 11 FRENCH LIVER-TRANSPLANT RECIPIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].

BOUSCARAT, F ;

SAMUEL, D ;

SIMON, F ;

DEBAT, P ;

BISMUTH, H ;

SAIMOT, AG .

CLINICAL INFECTIOUS DISEASES, 1994, 19 (05) :854-859

[2] Interaction between nelfinavir and tacrolimus after orthoptic liver transplantation in a patient coinfected with HIV and hepatitis C virus (HCV) [J].

Schvarcz, R ;

Rudbeck, G ;

Söderdahl, G ;

Ståhle, L .

TRANSPLANTATION, 2000, 69 (10) :2194-2195

[3] Concomitant human immunodeficiency virus protease inhibitor therapy markedly reduces tacrolimus metabolism and increases blood levels [J].

Sheikh, AM ;

Wolf, DC ;

Lebovics, E ;

Goldberg, R ;

Horowitz, HW .

TRANSPLANTATION, 1999, 68 (02) :307-309

[4] Should all human immunodeficiency virus-infected patients with end-stage renal disease be excluded from transplantation? The views of US transplant centers [J].

Spital, A .

TRANSPLANTATION, 1998, 65 (09) :1187-1191

[5] TRANSPLANTATION IN HIV+ PATIENTS [J].

TZAKIS, AG ;

COOPER, MH ;

DUMMER, JS ;

RAGNI, M ;

WARD, JW ;

STARZL, TE .

TRANSPLANTATION, 1990, 49 (02) :354-358

← 1 →